Cannara Biotech Announces Notice Of Annual General Meeting Of Shareholders

Cannara has announced that it will host the company’s annual general meeting of shareholders on January 25th, 2024 at 11:00 am EST.  The meeting will be held by way of a live webcast and teleconference. Cannara Biotech Inc., a client of our Bristol Investor Relations company, is a vertically integrated producer of premium-grade cannabis and derivative product offerings.…

Read More

Adcore Launches Feeditor Plus+ Application for E-commerce Enterprises

Adcore Inc. has unveiled its latest Marketing Cloud application, Feeditor Plus+. This new tool is tailored to support enterprises with large inventories and significant advertising budgets, streamlining their digital advertising efforts. Adcore Inc., a client of our Bristol Investor Relations company in Canada, is a leading e-commerce advertising management and automation platform to leverage digital…

Read More

Viemed to Centralize Market for Common Shares on NASDAQ Through Voluntary Delisting from TSX

Viemed Healthcare, Inc. has applied and received approval from the Toronto Stock Exchange for the voluntary delisting of its common shares from the TSX. The delisting from TSX will not affect the company’s listing on the NASDAQ Capital Market. Viemed Healthcare, Inc., a client of our Bristol Investor Relations company, is a national leader in…

Read More

Thunderbird Announces Commencement of Normal Course Issuer Bid

Thunderbird Entertainment Group Inc. has announced that it has received approval from the TSX Venture Exchange of its Notice of Intention to Make a Normal Course Issuer Bid. Under the NCIB, the company may purchase for cancellation up to 3,418,509 common shares (representing approximately 10% of its public float of 34,185,095 shares as of December…

Read More